Stay updated with breaking news from Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pre-specified, blinded interim analysis for sample size re-estimation indicates that the ongoing Phase 2/3 study in Alzheimer’s Disease is sufficiently powered to continue as planned without any...
By Adam L. Cataldo Annovis Bio's shares gained after the company said an independent statistical group concluded that its Phase 2/3 study could continue as...
Shares of Annovis Bio, Inc. (ANVS) are up 16% on Thursday after the company shared positive news about its Alzheimer's study. ANVS is trading on the New York Stock Exchange at $9.
NEW YORK--(BUSINESS WIRE)--Sep 19, 2023--
Another study showed vaginal estrogen during prolapse repair did not affect surgical outcomes